Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ·Healthcare·Biotechnology
$5.95
+3.66%
Mkt Cap $353.60M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (6 analysts)
$14.25
Range $7.50 – $21.00
Implied Upside
+139.5%
Consensus $14.25 vs current $5.95
NASDAQ·Healthcare·Biotechnology
$5.95
+3.66%
Mkt Cap $353.60M
Buy
4
Hold
1
Sell
0
Price Target (6 analysts)
$14.25
Range $7.50 – $21.00
+139.5%
Consensus $14.25 vs current $5.95